Keyphrases
Abnormal Expansion
9%
Anti-hypertension Drug
9%
Cardio
9%
Chemical Profiling
9%
Chinese Herbal Formula
9%
Cholesterol Toxicity
9%
Clinical Treatment
9%
Combined Method
9%
Echocardiographic
9%
Guizhi Decoction
100%
High Mortality Rate
9%
High-density Lipoprotein Cholesterol (HDL-C)
9%
Hypoxia
100%
Hypoxia Stress
9%
Hypoxia-inducible factor-1α (HIF-1α)
18%
Inflammation
9%
Inflammatory Cytokines
9%
L-carnitine
9%
Lipid Droplets
9%
Lipid Toxicity
100%
Low-density Lipoprotein Cholesterol (LDL-C)
9%
Mitochondrial Function
9%
Molecular Biology
9%
Molecular Mechanism
9%
Morphological Measurements
9%
MS-MS
9%
Naringin
9%
Neohesperidin
9%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
9%
Oxidative Stress
9%
Pathological Process
9%
Pharmacological Effects
9%
Pharmacological Mechanism
9%
Pulmonary Artery Pressure
9%
Pulmonary Artery Smooth muscle Cells (PASMCs)
18%
Pulmonary Hypertension
100%
Pulmonary Vascular Disease
9%
Pulmonary Vascular Remodeling
100%
Rat Model
9%
Therapeutic Potential
27%
UHPLC-QTOF-MS
9%
Pharmacology, Toxicology and Pharmaceutical Science
Carnitine
12%
Cytokine
12%
Fat Droplet
12%
Hypoxia
100%
Inflammation
12%
Mortality Rate
12%
Naringin
12%
Neohesperidin
12%
Pulmonary Hypertension
100%
Pulmonary Vascular Disease
12%
Rat Model
12%
Traditional Chinese Medicine
12%
Transcription Factor Nrf2
12%
Ultra High Performance Liquid Chromatography
12%
Vascular Remodeling
100%